earnings Archives | Be Korea-savvy
Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates

Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates

SHANGHAI, China, Aug. 30 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2023 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of 30 June 2023, the company’s total revenue was [...]

Nongshim’s Q2 Net Profit Jumps Over 60 pct on Higher Demand, Growth in Overseas Markets

Nongshim’s Q2 Net Profit Jumps Over 60 pct on Higher Demand, Growth in Overseas Markets

SEOUL, Aug. 11 (Korea Bizwire) — South Korea’s top instant noodle maker Nongshim Co. said Friday its net profit jumped more than 60 percent in the second quarter from a year earlier largely thanks to stronger demand for instant noodles amid high inflation and growth in overseas markets. Net profit for the three months ended [...]

Gorilla Technology Group Reports First Half 2023 Financial Results

Gorilla Technology Group Reports First Half 2023 Financial Results

LONDON, Aug. 9 (Korea Bizwire) — Gorilla Technology Group Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, today reported its unaudited financial results for the six months ended June 30, 2023. Highlights Booked sales exceeded internal target of $41 million, standing at $272 million, [...]

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results

Mont-Saint-Guibert, Belgium, Aug. 8, (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the second quarter and first half of 2023. Recent Financial and Operating Highlights Presented 12-month efficacy data1 on the [...]